Productive Value of Sonographic Measurement of Optic Nerve in Transitional Multiple

Launched by ASSIUT UNIVERSITY · May 29, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how measuring the diameter of the optic nerve using ultrasound can help doctors understand early signs of nerve damage and disability in people with relapsing remitting multiple sclerosis (RRMS). The researchers want to see if this measurement, along with tests that check how well the visual system is working, can serve as a useful marker for monitoring the disease.

To be eligible for the trial, participants need to be between 15 and 50 years old, of any gender, and must have RRMS without a history of optic neuritis (an inflammation of the optic nerve). Unfortunately, individuals with certain eye conditions, those who have received specific MS treatments recently, or those with alternative diagnoses will not be able to participate. If you join the study, you can expect to undergo non-invasive tests to measure the optic nerve and assess visual function, helping to advance knowledge about RRMS and potentially improve future treatments.

Gender

ALL

Eligibility criteria

• • 1. inclusion criteria
• • 1. both sex
• • 2. Age group from 15 to 50 yrs
• • 3. Patient with RRMS without history of optic neuritis
• 2. Exclusion criteria :
• • 1. History of previous optic neuritis
• • 2. Medical illness of eye(e.g. diabetes and hypertension)
• • 3. MS patient on fingolimod for 6 months or more
• • 4. Relapsing or use of steroid in the past 3 months
• • 5. Proved alternative diagnosis (neuromyelitis optica )
• • 6. local eye disease or surgery